Medical Design Technology

Device Companies

Subscribe to Device Companies

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

Pacemaker Payment Plans, Courtesy of Medtronic

February 5, 2013 7:29 am | by Mass Device | News | Comments

Medtronic offers patients in India the option to pay off a pricey cardiac implants in installments. Medtronic's (NYSE:MDT) India division is offering patients an "easy monthly installment" plan to help families cope with the high cost of cardiac implants. The EMI program is available in 60 hospitals in 18 cities and applies to a handful of medical devices...

Device Tax: We Need Action by Summer, Paulsen Says

February 4, 2013 3:43 pm | by Mass Device | News | Comments

Medical device industry advocate Rep. Erik Paulsen (R-Minn.) says Congress needs to act on the medical device tax by "late spring, early summer" this year. Rep. Erik Paulsen (R-Minn.), an unrelenting opponent of the medical device tax that took effect at the start of the year, still sees avenues for repeal tied to larger discussions of corporate tax reform. News Well, Capitol Hill, Medical Device Taxread more

Advertisement

Abbott Evolves to Focus on Diagnostics, with New High-Sensitivity Heart Attack Diagnostic Test

January 28, 2013 10:06 am | by GlobalData | News | Comments

January has been a month of change for healthcare giant Abbott, and a senior medical devices analyst from GlobalData asserts that the company’s latest cardiac diagnostics product represents the first step in a line of new diagnostic products which will act to deliver growth over the next few years.

Covidien Supports Centers for Medicare & Medicaid Services Quality Measure #3040

January 21, 2013 9:24 am | by Covidien | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announces its support for the Centers of Medicare & Medicaid Services (CMS) proposed quality measure #3040, currently considered for a Medicare program rule. Quality measures help CMS assess performance of hospitals participating...

Emerging Biologics: Breaking Down Barriers with Device Companies and the FDA

January 3, 2013 3:29 pm | by Christopher Velis | Articles | Comments

Medical devices and man-made materials have achieved major advances over recent decades. However, a new drumbeat is sounding in healthcare, as the steady growth in the use of biologics in medical procedures is gaining traction. Man-made materials will always have a place in the case of acute trauma, but biologics have the potential to take over as the most effective solution for degenerative conditions.

Biocompatibility and Performance of Medical Devices

January 2, 2013 2:19 pm | Events

Join us for a rare gathering of international thought leaders sharing insights on crucial topics affecting our industries today. This comprehensive symposium is based on the definitive new publication “Biocompatibility and Performance of Medical Devices” assembled by ANSM expert Dr. Jean-Pierre Boutrand.

Biocompatibility and Performance of Medical Devices

January 2, 2013 2:15 pm | Events

Join us for a rare gathering of international thought leaders sharing insights on crucial topics affecting our industries today. This comprehensive symposium is based on the definitive new publication “Biocompatibility and Performance of Medical Devices” assembled by ANSM expert Dr. Jean-Pierre Boutrand.  

Advertisement

Singapore Pumps Innovation into the Heart of Asia’s Growing Cardio Device Industry

December 19, 2012 4:57 pm | by Kevin Lai | Blogs | Comments

In the time it takes to read this piece, 30 Chinese men and women will die from heart disease. This staggering statistic means that as Asia continues to witness astonishing growth and development, Asians will increasingly wrestle with the disease. Heart disease is already the number one killer in China and India, and is fast on the rise throughout Southeast Asia, where the World Health Organization reports that cardiovascular diseases accounts for 27% of all deaths.

Abbott Board of Directors Approves Separation of AbbVie and Declares Special Dividend Distribution of AbbVie Stock

November 30, 2012 9:02 am | by Abbott | News | Comments

Abbott announced today that its board of directors has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie Inc., and declared a special dividend distribution of all of the outstanding shares of AbbVie common stock.

Merit Medical Signs Agreement to Acquire Thomas Medical Products, a Unit of GE Healthcare

November 27, 2012 9:55 am | by Globe Newswire | News | Comments

Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has entered into a stock purchase agreement to acquire Thomas Medical Products, Inc. ("Thomas Medical") from GE Healthcare in an all-cash transaction valued at approximately $167 million...

Medtronic’s Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair

November 19, 2012 3:13 pm | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm repairs worldwide, the Endurant AAA stent graft system from Medtronic, Inc. continues to show robust results in mid-term follow-up, according to two-year clinical data presented at VEITHsymposium, which concluded yesterday in New York.

Depuy Synthes Spine Launches New Image Guided Instrumentation for Viper® 2 and Expedium® Spine Systems at NASS

October 26, 2012 9:40 am | News | Comments

DePuy Synthes Spine announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.

Depuy Synthes Spine Launches First Access System for Minimally Invasive Posterior-Lateral Fusion

October 24, 2012 11:27 am | by DePuy Synthes Spine | News | Comments

DePuy Synthes Spine announced the launch of the SPOTLIGHT® PL Access System, the first access system designed specifically for minimally invasive posterior-lateral fusion. The announcement was made here at the North American Spine Society (NASS) 27th annual meeting, where the company is featuring its broad portfolio of minimally invasive and traditional spinal surgery solutions.

Medtronic Engages Cardiologists in ‘World Diabetes Day’

October 24, 2012 11:24 am | by Medtronic | News | Comments

Reinforcing its commitment to people with diabetes, Medtronic, Inc. (NYSE: MDT) is promoting its long-standing partnership with the International Diabetes Federation (IDF) through a new initiative surrounding “World Diabetes Day” on Nov. 14 that aims to engage interventional cardiologists worldwide in raising awareness of the connection between diabetes and coronary artery disease.

Depuy Synthes Spine Launches New Anterior Cervical Interbody Fusion System

October 24, 2012 11:21 am | by DePuy Synthes Spine | News | Comments

DePuy Synthes Spine today announced the launch of the ACIS™ Anterior Cervical Interbody Spacer System (ACIS System), a comprehensive set of spacers and instrumentation for anterior cervical discectomy and fusion (ACDF). The announcement was made here at the North American Spine Society (NASS) 27th annual meeting, where the company is featuring the ACIS System alongside the ZERO-P® VA...

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

October 23, 2012 11:44 am | by Medtronic | News | Comments

For the treatment of long lesions and small vessels –– two challenging characteristics of coronary artery disease commonly found in patients with diabetes –– the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) delivered successful clinical results, according to new data presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Medtronic Announces Approval and Launch of Japan’s First MR-Conditional Pacemaker System

October 18, 2012 12:32 pm | by Medtronic | News | Comments

Medtronic, Inc. (NYSE: MDT), today announced the Japanese regulatory approval and launch of the Advisa DR MRI™ SureScan™ pacing system. The Advisa MRI system is the first and only MR-Conditional pacemaker available to patients in Japan, the world’s second largest market for medical devices.

Covidien Announces FDA 510(k) Clearance and CE Mark for Nellcor Bedside Respiratory Patient Monitoring System

October 4, 2012 11:25 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced U.S. Food and Drug Administration 510(k) clearance and European Economic Area (EEA) CE Mark approval for the Covidien Nellcor™ Bedside Respiratory Patient Monitoring system.

Analyst Insight: Abbott’s Absorb is the New Face of the Stent Industry

September 27, 2012 9:29 am | by GlobalData | News | Comments

The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will revolutionize the stent industry. On September 25th, 2012, Abbott announced the launch of its drug-eluting bioabsorbable stent, Absorb, in Europe, the Middle East and parts of Asia Pacific and Latin America. Absorb, which received CE mark certification in 2011, is used to treat coronary artery disease.

BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care

September 19, 2012 12:06 pm | News | Comments

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety[i-iii]. Patients who reported injection-related pain or embarrassment also admitted they intentionally skipped insulin injections more often. A study by the American Association of Diabetes Educators (AADE) revealed that...

Continuous spinal cord stimulation improves heart function

August 27, 2012 9:21 am | by European Society of Cardiology | News | Comments

Spinal cord stimulation improves heart function and could become a novel treatment option for heart failure, according to research presented at the ESC Congress 2012 today by Professor Hung-Fat Tse from Hong Kong. Heart failure is a progressive weakening of the heart muscle. It is a chronic condition that occurs when the heart cannot pump blood to meet the body’s needs.

GE Healthcare Recognized by Industrial Designers Society of America for Design Excellence

August 23, 2012 11:43 am | News | Comments

GE Healthcare announced that it has been recognized by the Industrial Designers Society of America (IDSA) with three International Design Excellence Awards (IDEA) for Medical and Scientific Products. The IDEA program is a celebration of design excellence in products, sustainability, interaction design, packaging, strategy, research, and concepts.

Medtronic reports first quarter earnings

August 23, 2012 6:09 am | by I-Micronews | News | Comments

The Company reported worldwide first quarter revenue of $4.008 billion, an increase of 5 percent on a constant currency basis after adjusting for a $119 million negative foreign currency impact or 2 percent as reported. As reported, first quarter net earnings were $864 million, or $0.83 per diluted share...

M&A: The top 15 acquirers among medical device companies

August 6, 2012 3:37 pm | by Mass Device | News | Comments

A look at the most acquisitive medical device companies, culled from MassDevice.com's Big 100 database of more than 1,300 medical device industry transactions. More than $50 billion was spent on acquisitions by Big 100 medical device companies from the beginning of 2011 through the 1st half of 2012.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading